Activation of dendritic cells by low molecular weight oyster polysaccharides

International Immunopharmacology

Volumn 44, Issue , 2017, Pages 183-190

  Zhong, Ming ^a   Zhong, Cheng ^b   Wang, Tingting ^c   Hu, Pei ^d   Wang, Guanghui ^a   Ren, Rujing ^a   Zhang, Jing ^a   Gao, Huijei ^a   Cui, Wen ^a   Duan, Wenjuan ^e   Che, Jiantu ^f  

^a JINING MEDICAL UNIVERSITY   (China)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c PEOPLE S HOSPITAL OF RIZHAO   (China)

^d SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^e Shandong Analysis and Test Center   (China)

^f S V Biological Science and Technology Co   (China)

Author keywords

Dendritic cells; MAPK; Maturation; Oyster; Polysaccharides

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; LOW MOLECULAR WEIGHT OYSTER POLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; POLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 2; TLR4 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; MIXED LYMPHOCYTE REACTION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OYSTER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; BONE MARROW CELL; C3H MOUSE; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; OSTREIDAE; POLYSACCHARIDES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85009826573     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2017.01.018     Document Type: Article

References (34)

1. [1] Gilboa, E., DC-based cancer vaccines. J. Clin. Invest. 117:5 (2007), 1195–1203.
2. [2] Banchereau, J., Palucka, A.K., Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5:4 (2005), 296–306.
3. [3] Palucka, K., Banchereau, J., Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12:4 (2012), 265–277.
4. [4] Palucka, K., Ueno, H., Banchereau, J., Recent developments in cancer vaccines. J. Immunol. 186:3 (2011), 1325–1331.
5. [5] Lichtenegger, F.S., Mueller, K., Otte, B., et al. CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells. PLoS One, 7(9), 2012, e44266.
6. + Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206:7 (2009), 1589–1602.
7. [7] McKee, A.S., Munks, M.W., Marrack, P., How do adjuvants work? Important considerations for new generation adjuvants. Immunity 27:5 (2007), 687–690.
8. [8] Steinman, R.M., Banchereau, J., Taking dendritic cells into medicine. Nature 449:7161 (2007), 419–426.
9. [9] Harding, F.A., McArthur, J.G., Gross, J.A., et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:6370 (1992), 607–609.
10. [10] Park, S.K., Kim, G.Y., Lim, J.Y., et al. Acidic polysaccharides isolated from Phellinus linteus induce phenotypic and functional maturation of murine dendritic cells. Biochem. Biophys. Res. Commun. 312:2 (2003), 449–458.
11. [11] Kim, G.Y., Ko, W.S., Lee, J.Y., et al. Water extract of Cordyceps militaris enhances maturation of murine bone marrow-derived dendritic cells in vitro. Biol. Pharm. Bull. 29:2 (2006), 354–360.
12. [12] Wang, Y.K., He, H.L., Wang, G.F., et al. Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice. Mar. Drugs 8:2 (2010), 255–268.
13. [13] Cheng, J.Y., Ng, L.T., Lin, C.L., et al. Pacific oyster-derived polysaccharides enhance antigen-specific T helper (Th)1 immunity in vitro and in vivo. Immunopharmacol. Immunotoxicol. 35:2 (2013), 235–240.
14. [14] Staub, A.M., Removal of protein: sevag method. Whistler, R.L., (eds.) Methods in Carbohydrate Chemistry, 1965, New York, Academic Press Inc., 5–8.
15. [15] Scarlett, U.K., Rutkowski, M.R., Rauwerdink, A.M., et al. Cancer progression is controlled by phenotypic changes in dendritic cells. J. Exp. Med. 209:3 (2012), 495–506.
16. [16] Suryawanshi, A., Manicassmy, S., Tumor induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: a novel therapeutic target for cancer immunotherapy. Oncoimmunol., 4(12), 2015, e1052932.
17. [17] Kim, H.S., Kim, J.Y., Kang, J.S., et al. Cordlan polysaccharide isolated from mushroom Cordyceps militaris induces dendritic cell maturation through toll-like receptor 4 signalings. Food Chem. Toxicol. 48:7 (2010), 1926–1933.
18. [18] Peng, S., Zhao, L.H., Chen, Z., et al. Regulation on maturation and function of dendritic cells by Astragalus mongholicus polysaccharides. Int. Immunopharmacol. 6:7 (2006), 1161–1166.
19. + T cells. Immunol. Rev. 211 (2006), 81–92.
20. + T cell populations lacking helper function. Nat. Immunol. 6:2 (2005), 163–170.
21. [21] Napolitani, G., Rinaldi, A., Bertoni, F., et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6:8 (2005), 769–776.
22. [22] Mailliard, R.B., Wankowicz-Kalinska, A., Cai, Q., et al. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 64:17 (2004), 5934–5937.
23. [23] Zobywalski, A., Javorovic, M., Frankenberger, B., et al. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70. J. Transl. Med., 5(18), 2007, 10.1186/1479-5876-5-18.
24. [24] Boullart, A.C., Aarntzen, E.H., Verdijk, P., et al. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. Cancer Immunol. Immunother. 57:11 (2008), 1589–1597.
25. [25] Spranger, S., Javorovic, M., Bürdek, M., et al. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075. J. Immunol. 185:1 (2010), 738–747.
26. [26] Beck, B., Dorfel, D., Lichtenegger, F.S., et al. Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission. J. Transl. Med., 9(151), 2011, 10.1186/1479-5876-9-151.
27. [27] Uematsu, S., Akira, S., Toll-like receptors and innate immunity. J. Mol. Med. (Berl.) 84:9 (2006), 712–725.
28. [28] West, A.P., Koblansky, A.A., Ghosh, S., Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 22 (2006), 409–437.
29. [29] Seya, T., Matsumoto, M., The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol. Immunother. 58:8 (2009), 1175–1184.
30. [30] Matsumoto, M., Seya, T., TLR3: interferon induction by double-stranded RNA including poly (I: C). Adv. Drug Deliv. Rev. 60:7 (2008), 805–812.
31. [31] Krummen, M., Balkow, S., Shen, L., et al. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. J. Leukoc. Biol. 88:1 (2010), 189–199.
32. [32] Bohnenkamp, H.R., Papazisis, K.T., Burchell, J.M., et al. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Cell. Immunol. 247:2 (2007), 72–84.
33. [33] Brown, J., Wang, H., Hajishengallis, G.N., et al. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. 90:4 (2011), 417–427.
34. [34] Rogers, N.C., Slack, E.C., Edwards, A.D., et al. Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22:4 (2005), 507–517.